Clinical Trial

Investigation of the Interplay Between Local Oral Inflammation, Microbiota and Systemic Immune Responses.

Study acronym: ILIMSIR
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a clinical research study designed to measure changes in inflammation and the oral microbiome during a phase of good oral hygiene and the absence of oral hygiene. The goal of the study is to investigate the interplay between local oral inflammation, microbiota and systemic immune responses.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-12 -> 2027-06 2026-05-27
minor Completion pushed: 2026-12 -> 2027-06 2026-05-27
Trial Details
NCT Number NCT06966492
Lead Sponsor Colgate Palmolive
Collaborators: The University of Texas Health Science Center, Houston
Conditions Gingival Inflammation
Enrollment 20 participants
Start Date 2026-06
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-26